Founded in 2019
BigHat Biosciences aims to radically reduce the difficulty of designing therapeutic proteins. Our AI-first experimental platform, which integrates a high-speed wet lab with AI/ML techniques, enables drug developers to create better antibodies faster and undertake novel biotherapeutic designs far bey...
Francisco Gimenez
Director Board Of Directors
Jon Wojciak
Senior Director of Preclinical Development
Srujan Vadlamudi
Research Associate II
Elisabeth Visser
Research Associate
Tim Park
In vivo Operations Manager
Eva Morales Boettcher
Senior Research Associate
Harshitha Gamahewage
Business Operations Specialist
Austin Prater
Scientist-Display Technologies
Danielle Landrein
Head of Talent